Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancers

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 5, 2008, Pages 1343-1348

  Fukui, Takayuki ^a   Mori, Shoichi ^a   Hatooka, Shunzo ^a   Shinoda, Masayuki ^a   Mitsudomi, Tetsuya ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 56249101688     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.12.085     Document Type: Article

References (31)

1. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 111 (1997) 1710-1717
2. Goya T., Asamura H., Yoshimura H., Kato H., Shimokata K., Tsuchiya R., et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 50 (2005) 227-234
3. Inoue K., Sato M., Fujimura S., Sakurada A., Takahashi S., Usuda K., et al. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993. J Thorac Cardiovasc Surg 116 (1998) 407-411
4. Jassem J., Skokowski J., Dziadziuszko R., Jassem E., Szymanowska A., Rzyman W., et al. Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. J Thorac Cardiovasc Surg 119 (2000) 1141-1146
5. Adebonojo S.A., Bowser A.N., Moritz D.M., and Corcoran P.C. Impact of revised stage classification of lung cancer on survival: a military experience. Chest 115 (1999) 1507-1513
6. Naruke T., Tsuchiya R., Kondo H., and Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 71 (2001) 1759-1764
7. Urschel J.D., Urschel D.M., Anderson T.M., Antkowiak J.G., and Takita H. Prognostic implications of pulmonary satellite nodules: are the 1997 staging revisions appropriate?. Lung Cancer 21 (1998) 83-87 discussion 89-91
8. Kameyama K., Huang C.L., Liu D., Okamoto T., Hayashi E., Yamamoto Y., et al. Problems related to TNM staging: patients with stage III non-small cell lung cancer. J Thorac Cardiovasc Surg 124 (2002) 503-510
9. Koike T., Terashima M., Takizawa T., Aoki T., Watanabe T., and Akamatsu H. Results of surgery for primary lung cancer based on the new international staging system. Jpn J Thorac Cardiovasc Surg 47 (1999) 313-317
10. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2 (2007) 706-714
11. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 593-602
12. Rusch V.W., Crowley J., Giroux D.J., Goldstraw P., Im J.G., Tsuboi M., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 603-612
13. Postmus P.E., Brambilla E., Chansky K., Crowley J., Goldstraw P., Patz Jr. E.F., et al. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2 (2007) 686-693
14. Union Internationale Contre le Cancer. TNM classification of malignant tumours. 5th ed. (1997), Union Internationale Contre le Cancer, Geneva
15. Union Internationale Contre le Cancer. TNM classification of malignant tumours. 6th ed. (2002), Union Internationale Contre le Cancer, Geneva
16. Yano M., Arai T., Inagaki K., Morita T., Nomura T., and Ito H. Intrapulmonary satellite nodule of lung cancer as a T factor. Chest 114 (1998) 1305-1308
17. Heyneman L.E., Herndon J.E., Goodman P.C., and Patz Jr. E.F. Stage distribution in patients with a small (< or = 3 cm) primary nonsmall cell lung carcinoma. Implication for lung carcinoma screening. Cancer 92 (2001) 3051-3055
18. Gajra A., Newman N., Gamble G.P., Abraham N.Z., Kohman L.J., and Graziano S.L. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 42 (2003) 51-57
19. Wisnivesky J.P., Yankelevitz D., and Henschke C.I. The effect of tumor size on curability of stage I non-small cell lung cancers. Chest 126 (2004) 761-765
20. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75 (1995) 2844-2852
21. Asamura H., Goya T., Koshiishi Y., Sohara Y., Tsuchiya R., and Miyaoka E. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. J Thorac Cardiovasc Surg 132 (2006) 316-319
22. Asamura H., Suzuki K., Watanabe S., Matsuno Y., Maeshima A., and Tsuchiya R. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 76 (2003) 1016-1022
23. Miller D.L., Rowland C.M., Deschamps C., Allen M.S., Trastek V.F., and Pairolero P.C. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 73 (2002) 1545-1551
24. Fukui T., Sakakura N., Mori S., Hatooka S., Shinoda M., Yatabe Y., et al. Controversy about small peripheral lung adenocarcinomas: how should we manage them?. J Thorac Oncol 2 (2007) 546-552
25. Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J.P., Vansteenkiste J., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
26. Winton T., Livingston R., Johnson D., Rigas J., Johnston M., Butts C., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352 (2005) 2589-2597
27. Douillard J.Y., Rosell R., Delena M., Legroumellec A., Torres A., and Carpagnano F. ANITA: phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association. J Clin Oncol 23 (2005) 624s
28. Strauss G.M., Herndon J.E., Maddaus M.A., Johnston D.W., Johnson E.A., and Watson D.M. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update on Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 24 (2006) 365s
29. Fukui T., Mori S., Yokoi K., and Mitsudomi T. Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol 1 (2006) 120-125
30. Naruke T., Suemasu K., and Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76 (1978) 832-839
31. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723